Delivery Order SPE2DB22D3004-SPE2DB25FPK51

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,464.15, is for the delivery of fluticasone-salmeterol 230-21 12GM medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of January 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of FLUTICASONE-SALMETEROL 230-21 12GM, a pharmaceutical product. The $21,973.87 fixed-price delivery order contract has an ultimate completion date of August 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $6,010.55, is for the supply of FLUTICASONE-SALMETEROL 45-21 12GM, a pharmaceutical product. The contract is for a firm fixed price and has an ultimate completion date of August 7, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $16,871.42 to the Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. This contract is for the procurement of the pharmaceutical product Fluticasone-Salmeterol 230-21 12GM. The contract has a Firm Fixed Price pricing type and an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a $1,798.67 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Fluticasone-Salmeterol, a combination respiratory medication, to support various federal healthcare programs and military treatment facilities. The contract has an ultimate completion date of July 25, 2024 and does not utilize a set-aside designation. Amerisourcebergen holds several Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $8,396.59 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM pharmaceutical products and has a completion date of May 1, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This is a $5,467.73 delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM, a critical medical supply. The contract has an ultimate completion date of August 8, 2024. AmerisourceBergen, a large pharmaceutical distributor, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 45-21 12GM, a critical medication. The $1,649.87 firm fixed price contract has a completion date of September 5, 2024. Amerisourcebergen has significant existing Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of FLUTICASONE-SALMETEROL 230-21 12GM, a pharmaceutical product. The contract has a firm fixed price of $3,322.70 and an ultimate completion date of July 25, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with significant Indefinite Delivery Contracts (IDCs) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,705.50 firm fixed price contract is for the supply of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, with a completion date of May 9, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPK51
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,794.84 fixed-price contract is for the supply of FLUTICASONE-SALMETEROL 230-21 12GM, a pharmaceutical product. The contract has a completion date of February 6, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/7/25, 9:44 AM